Related Experiment Videos
[Thoracic and lumbar myelography with metrizamid (author's transl)]
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|June 1, 1977
Abstract:
With the new x-ray medium Metrizamid it is possible to perform almost complication-free lumbar and thoracic myelography. In an experience the type of complications arising were reduced to moderate headaches, mild nausea occasional dissiness. No convulsions were seen. The number of complications are less than with other watersoluble contrast medium.
Insights
Metrizamid allows for nearly complication-free myelography, significantly reducing adverse effects like headaches and nausea compared to other contrast agents. This new x-ray medium offers a safer option for lumbar and thoracic imaging procedures.
Area of Science:
- Radiology
- Medical Imaging
- Neurology
Context:
- Lumbar and thoracic myelography are diagnostic imaging procedures.
- Traditional water-soluble contrast media can cause significant complications.
Purpose:
- To evaluate the safety and efficacy of Metrizamid for myelography.
- To compare complication rates of Metrizamid with other contrast agents.
Summary:
- Metrizamid enables almost complication-free lumbar and thoracic myelography.
- Reported complications were limited to mild headaches, nausea, and occasional dizziness.
- No convulsions were observed, and overall complication rates were lower than with other water-soluble contrast media.
Impact:
- Metrizamid represents a safer alternative for myelography procedures.
- Reduced complications can improve patient outcomes and tolerance.
- This advancement may encourage wider use of myelography for spinal diagnostics.